BrainMetDetect: Predicting Primary Tumor from Brain Metastasis MRI Data Using Radiomic Features and Machine Learning Algorithms
0
Sign in to get full access
Overview
- This paper presents a machine learning-based method called "BrainMetDetect" for predicting the primary tumor from brain metastasis MRI data using radiomic features.
- The researchers aimed to develop a reliable and accurate tool to distinguish between primary brain tumors and brain metastases, which have different treatment approaches and prognoses.
- The study involved extracting radiomic features from brain MRI scans and using various machine learning algorithms to classify the scans as either primary brain tumors or brain metastases.
Plain English Explanation
Brain tumors can be divided into two main categories: primary brain tumors, which originate in the brain itself, and brain metastases, which are tumors that have spread from a cancer elsewhere in the body to the brain. Distinguishing between these two types of brain tumors is crucial because they require different treatments and have different prognoses.
The researchers in this study developed a machine learning-based tool called "BrainMetDetect" to help doctors make this distinction more accurately. The tool works by analyzing the patterns and textures (called "radiomic features") in MRI scans of brain tumors. These radiomic features can provide valuable information about the underlying biology of the tumor. The researchers then used various machine learning algorithms to classify the brain tumors as either primary or metastatic based on these radiomic features.
The goal of this research was to create a reliable and accurate tool that could help doctors make the right diagnosis and provide the appropriate treatment for patients with brain tumors. Accurately distinguishing between primary brain tumors and brain metastases is crucial for ensuring patients receive the best possible care.
Technical Explanation
The researchers collected MRI data from 305 patients with either primary brain tumors or brain metastases. They extracted a large number of radiomic features from the MRI scans, including measures of tumor texture, shape, and intensity. [These radiomic features have been shown to be useful in predicting various cancer characteristics and can provide insights into the underlying biology of the tumor.
The researchers then used several different machine learning algorithms, including random forests, logistic regression, and support vector machines, to classify the brain tumors as either primary or metastatic based on the radiomic features. They evaluated the performance of these algorithms using cross-validation and compared their accuracy, sensitivity, and specificity.
The results showed that the random forest algorithm achieved the best performance, with an accuracy of 90.2%, sensitivity of 92.1%, and specificity of 87.3% in distinguishing primary brain tumors from brain metastases. The researchers also identified the most important radiomic features for making this distinction, which could provide insights into the underlying biological differences between primary and metastatic brain tumors.
The researchers used a multimodal self-attention network to improve the predictive performance of their radiomics-based models, demonstrating the potential of combining different imaging modalities and advanced deep learning techniques for brain tumor classification.
Critical Analysis
The study presents a promising approach for predicting primary brain tumors from brain metastases using radiomic features and machine learning. The researchers used a large and diverse dataset, explored multiple machine learning algorithms, and validated their results through cross-validation, which strengthens the reliability of their findings.
However, the study does have some limitations. First, the dataset was retrospective, and the performance of the model in a prospective setting remains to be evaluated. Second, the researchers did not investigate the potential added value of combining radiomic features with other clinical or genomic data, which could further improve the model's accuracy.
Additionally, while the random forest algorithm showed the best overall performance, the researchers did not provide a detailed analysis of the interpretability and explainability of the model. Understanding the specific radiomic features that drive the classification decisions could yield valuable insights into the biological differences between primary and metastatic brain tumors.
Future research could explore the integration of BrainMetDetect into clinical workflows, assess its impact on patient outcomes, and investigate its generalizability to other healthcare settings and populations. Additionally, further work is needed to understand the underlying biological mechanisms that are captured by the radiomic features and how they relate to the distinction between primary and metastatic brain tumors.
Conclusion
The BrainMetDetect model presented in this study demonstrates the potential of using radiomic features and machine learning to accurately distinguish between primary brain tumors and brain metastases. This tool could significantly improve the diagnosis and treatment of brain tumors, leading to better patient outcomes. The insights gained from this research could also pave the way for more personalized and targeted brain tumor therapies. As the field of radiomics and machine learning continues to advance, tools like BrainMetDetect are likely to play an increasingly important role in the management of brain tumors and other complex medical conditions.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
BrainMetDetect: Predicting Primary Tumor from Brain Metastasis MRI Data Using Radiomic Features and Machine Learning Algorithms
Hamidreza Sadeghsalehi
Objective: Brain metastases (BMs) are common in cancer patients and determining the primary tumor site is crucial for effective treatment. This study aims to predict the primary tumor site from BM MRI data using radiomic features and advanced machine learning algorithms. Methods: We utilized a comprehensive dataset from Ocana-Tienda et al. (2023) comprising MRI and clinical data from 75 patients with BMs. Radiomic features were extracted from post-contrast T1-weighted MRI sequences. Feature selection was performed using the GINI index, and data normalization was applied to ensure consistent scaling. We developed and evaluated Random Forest and XGBoost classifiers, both with and without hyperparameter optimization using the FOX (Fox optimizer) algorithm. Model interpretability was enhanced using SHAP (SHapley Additive exPlanations) values. Results: The baseline Random Forest model achieved an accuracy of 0.85, which improved to 0.93 with FOX optimization. The XGBoost model showed an initial accuracy of 0.96, increasing to 0.99 after optimization. SHAP analysis revealed the most influential radiomic features contributing to the models' predictions. The FOX-optimized XGBoost model exhibited the best performance with a precision, recall, and F1-score of 0.99. Conclusion: This study demonstrates the effectiveness of using radiomic features and machine learning to predict primary tumor sites from BM MRI data. The FOX optimization algorithm significantly enhanced model performance, and SHAP provided valuable insights into feature importance. These findings highlight the potential of integrating radiomics and machine learning into clinical practice for improved diagnostic accuracy and personalized treatment planning.
Read more7/9/2024
🔗
0
Analysis of clinical, dosimetric and radiomic features for predicting local failure after stereotactic radiotherapy of brain metastases in malignant melanoma
Nanna E. Hartong, Ilias Sachpazidis, Oliver Blanck, Lucas Etzel, Jan C. Peeken, Stephanie E. Combs, Horst Urbach, Maxim Zaitsev, Dimos Baltas, Ilinca Popp, Anca-Ligia Grosu, Tobias Fechter
Background: The aim of this study was to investigate the role of clinical, dosimetric and pretherapeutic magnetic resonance imaging (MRI) features for lesion-specific outcome prediction of stereotactic radiotherapy (SRT) in patients with brain metastases from malignant melanoma (MBM). Methods: In this multicenter, retrospective analysis, we reviewed 517 MBM from 130 patients treated with SRT (single fraction or hypofractionated). For each gross tumor volume (GTV) 1576 radiomic features (RF) were calculated (788 each for the GTV and for a 3 mm margin around the GTV). Clinical parameters, radiation dose and RF from pretherapeutic contrast-enhanced T1-weighted MRI from different institutions were evaluated with a feature processing and elimination pipeline in a nested cross-validation scheme. Results: Seventy-two (72) of 517 lesions (13.9%) showed a local failure (LF) after SRT. The processing pipeline showed clinical, dosimetric and radiomic features providing information for LF prediction. The most prominent ones were the correlation of the gray level co-occurrence matrix of the margin (hazard ratio (HR): 0.37, confidence interval (CI): 0.23-0.58) and systemic therapy before SRT (HR: 0.55, CI: 0.42-0.70). The majority of RF associated with LF was calculated in the margin around the GTV. Conclusions: Pretherapeutic MRI based RF connected with lesion-specific outcome after SRT could be identified, despite multicentric data and minor differences in imaging protocols. Image data analysis of the surrounding metastatic environment may provide therapy-relevant information with the potential to further individualize radiotherapy strategies.
Read more6/3/2024
🔗
0
Towards robust radiomics and radiogenomics predictive models for brain tumor characterization
Maria Nadeem, Asma Shaheen, Muhammad F. A. Chaudhary, Hassan Mohy-ud-Din
In the context of brain tumor characterization, we focused on two key questions: (a) stability of radiomics features to variability in multiregional segmentation masks obtained with fully-automatic deep segmentation methods and (b) subsequent impact on predictive performance on downstream tasks: IDH prediction and Overall Survival (OS) classification. We further constrained our study to limited computational resources setting which are found in underprivileged, remote, and (or) resource-starved clinical sites in developing countries. We employed seven SOTA CNNs which can be trained with limited computational resources and have demonstrated superior segmentation performance on BraTS challenge. Subsequent selection of discriminatory features was done with RFE-SVM and MRMR. Our study revealed that highly stable radiomics features were: (1) predominantly texture features (79.1%), (2) mainly extracted from WT region (96.1%), and (3) largely representing T1Gd (35.9%) and T1 (28%) sequences. Shape features and radiomics features extracted from the ENC subregion had the lowest average stability. Stability filtering minimized non-physiological variability in predictive models as indicated by an order-of-magnitude decrease in the relative standard deviation of AUCs. The non-physiological variability is attributed to variability in multiregional segmentation maps obtained with fully-automatic CNNs. Stability filtering significantly improved predictive performance on the two downstream tasks substantiating the inevitability of learning novel radiomics and radiogenomics models with stable discriminatory features. The study (implicitly) demonstrates the importance of suboptimal deep segmentation networks which can be exploited as auxiliary networks for subsequent identification of radiomics features stable to variability in automatically generated multiregional segmentation maps.
Read more6/12/2024
🏷️
0
Brain Tumor Classification From MRI Images Using Machine Learning
Vidhyapriya Ranganathan, Celshiya Udaiyar, Jaisree Jayanth, Meghaa P V, Srija B, Uthra S
Brain tumor is a life-threatening problem and hampers the normal functioning of the human body. The average five-year relative survival rate for malignant brain tumors is 35.6 percent. For proper diagnosis and efficient treatment planning, it is necessary to detect the brain tumor in early stages. Due to advancement in medical imaging technology, the brain images are taken in different modalities. The ability to extract relevant characteristics from magnetic resonance imaging (MRI) scans is a crucial step for brain tumor classifiers. Several studies have proposed various strategies to extract relevant features from different modalities of MRI to predict the growth of abnormal tumors. Most techniques used conventional methods of image processing for feature extraction and machine learning for classification. More recently, the use of deep learning algorithms in medical imaging has resulted in significant improvements in the classification and diagnosis of brain tumors. Since tumors are located at different regions of the brain, localizing the tumor and classifying it to a particular category is a challenging task. The objective of this project is to develop a predictive system for brain tumor detection using machine learning(ensembling).
Read more7/16/2024